Lv58
924 积分 2024-09-13 加入
[Clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)]
1小时前
已完结
IgA Nephropathy
5小时前
已完结
Paroxysmal nocturnal haemoglobinuria
7天前
已完结
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
11天前
已完结
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
11天前
已完结
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
13天前
已完结
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
13天前
已完结
Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
14天前
已完结
7 basic science discoveries that changed the world
17天前
已完结
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
18天前
已完结
皖公网安备34019202002308
